Colitis Linked to Endoplasmic Reticulum Stress Induces Trypsin Activity Affecting Epithelial Functions.


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
25 Sep 2021
Historique:
pubmed: 21 2 2021
medline: 2 2 2022
entrez: 20 2 2021
Statut: ppublish

Résumé

Intestinal epithelial cells [IECs] from inflammatory bowel disease [IBD] patients exhibit an excessive induction of endoplasmic reticulum stress [ER stress] linked to altered intestinal barrier function and inflammation. Colonic tissues and the luminal content of IBD patients are also characterized by increased serine protease activity. The possible link between ER stress and serine protease activity in colitis-associated epithelial dysfunctions is unknown. We aimed to study the association between ER stress and serine protease activity in enterocytes and its impact on intestinal functions. The impact of ER stress induced by Thapsigargin on serine protease secretion was studied using either human intestinal cell lines or organoids. Moreover, treating human intestinal cells with protease-activated receptor antagonists allowed us to investigate ER stress-resulting molecular mechanisms that induce proteolytic activity and alter intestinal epithelial cell biology. Colonic biopsies from IBD patients exhibited increased epithelial trypsin-like activity associated with elevated ER stress. Induction of ER stress in human intestinal epithelial cells displayed enhanced apical trypsin-like activity. ER stress-induced increased trypsin activity destabilized intestinal barrier function by increasing permeability and by controlling inflammatory mediators such as C-X-C chemokine ligand 8 [CXCL8]. The deleterious impact of ER stress-associated trypsin activity was specifically dependent on the activation of protease-activated receptors 2 and 4. Excessive ER stress in IECs caused an increased release of trypsin activity that, in turn, altered intestinal barrier function, promoting the development of inflammatory process.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Intestinal epithelial cells [IECs] from inflammatory bowel disease [IBD] patients exhibit an excessive induction of endoplasmic reticulum stress [ER stress] linked to altered intestinal barrier function and inflammation. Colonic tissues and the luminal content of IBD patients are also characterized by increased serine protease activity. The possible link between ER stress and serine protease activity in colitis-associated epithelial dysfunctions is unknown. We aimed to study the association between ER stress and serine protease activity in enterocytes and its impact on intestinal functions.
METHODS METHODS
The impact of ER stress induced by Thapsigargin on serine protease secretion was studied using either human intestinal cell lines or organoids. Moreover, treating human intestinal cells with protease-activated receptor antagonists allowed us to investigate ER stress-resulting molecular mechanisms that induce proteolytic activity and alter intestinal epithelial cell biology.
RESULTS RESULTS
Colonic biopsies from IBD patients exhibited increased epithelial trypsin-like activity associated with elevated ER stress. Induction of ER stress in human intestinal epithelial cells displayed enhanced apical trypsin-like activity. ER stress-induced increased trypsin activity destabilized intestinal barrier function by increasing permeability and by controlling inflammatory mediators such as C-X-C chemokine ligand 8 [CXCL8]. The deleterious impact of ER stress-associated trypsin activity was specifically dependent on the activation of protease-activated receptors 2 and 4.
CONCLUSIONS CONCLUSIONS
Excessive ER stress in IECs caused an increased release of trypsin activity that, in turn, altered intestinal barrier function, promoting the development of inflammatory process.

Identifiants

pubmed: 33609354
pii: 6145784
doi: 10.1093/ecco-jcc/jjab035
doi:

Substances chimiques

Thapsigargin 67526-95-8
Trypsin EC 3.4.21.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1528-1541

Subventions

Organisme : French Ministry of Research and Technology
Organisme : National Agency for Research
ID : ANR JCJC-11JSV1 001 01-IBDase
Organisme : European Research Council
ID : ERC- 310973 PIPE
Pays : International
Organisme : French government
ID : ANR-11-EQPX-0003

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Núria Solà Tapias (N)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Alexandre Denadai-Souza (A)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Claire Rolland-Fourcade (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Muriel Quaranta-Nicaise (M)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Catherine Blanpied (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Marlène Marcellin (M)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.

Anissa Edir (A)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Corinne Rolland (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Carla Cirillo (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.
Laboratory for Enteric NeuroScience (LENS), TARGID, University of Leuven, Leuven, Belgium.

Gilles Dietrich (G)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Laurent Alric (L)

Pole Digestif, CHU, Toulouse, France.

Guillaume Portier (G)

Pole Digestif, CHU, Toulouse, France.

Sylvain Kirzin (S)

Pole Digestif, CHU, Toulouse, France.

Delphine Bonnet (D)

Pole Digestif, CHU, Toulouse, France.

Emmanuel Mas (E)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.
Pole Digestif, CHU, Toulouse, France.

Odile Burlet-Schiltz (O)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.

Céline Deraison (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Chrystelle Bonnart (C)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Nathalie Vergnolle (N)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.
Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.

Frédérick Barreau (F)

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH